CREG inhibits migration of human vascular smooth muscle cells by mediating IGF-II endocytosis

Experimental Cell Research

Volumn 315, Issue 19, 2009, Pages 3301-3311

  Han, Yaling ^a   Cui, Jifu ^a   Tao, Jie ^a   Guo, Liang ^a   Guo, Peng ^a   Sun, Mingyu ^a   Kang, Jian ^a   Zhang, Xiaolin ^a   Yan, Chenghui ^a   Li, Shaohua ^b  

^a SHENYANG NORTHERN HOSPITAL   (China)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

E1A; IGF II; Migration; Repressor protein; Vascular smooth muscle cells

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CELLULAR REPRESSOR OF E1A STIMULATED PROTEIN; GELATINASE B; GENE PRODUCT; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; UNCLASSIFIED DRUG;

ARTERY INTIMA PROLIFERATION; ARTICLE; CELL CULTURE; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INHIBITION KINETICS; INTERNALIZATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VIRUS RECOMBINANT; WESTERN BLOTTING;

EID: 70350404651     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.09.013     Document Type: Article

References (35)

1. Gerthoffer W.T. Mechanisms of vascular smooth muscle cell migration. Circ. Res. 100 (2007) 607-621
2. Hellstrom M., Kalen M., Lindahl P., Abramsson A., and Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126 (1999) 3047-3055
3. DeLong S.A., Moon J.J., and West J.L. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials 26 (2005) 3227-3234
4. Schwartz S.M. Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis. J. Clin. Invest. 99 (1997) 2814-2816
5. Hao H., Gabbiani G., Camenzind E., Bacchetta M., Virmani R., and Bochaton-Piallat M.L. Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 326-332
6. Vicente-Manzanares M., Webb D.J., and Horwitz A.R. Cell migration at a glance. J. Cell Sci. 118 (2005) 4917-4919
7. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., and Horwitz A.R. Cell migration: integrating signals from front to back. Science 302 (2003) 1704-1709
8. Abedi H., and Zachary I. Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc. Res. 30 (1995) 544-556
9. Veal E., Eisenstein M., Tseng Z.H., and Gill G. A cellular repressor of E1A-stimulated genes that inhibits activation by E2F. Mol. Cell Biol. 18 (1998) 5032-5041
10. Di Bacco A., and Gill G. The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor. Oncogene 22 (2003) 5436-5445
11. Han Y.L., Liu H.W., Kang J., Yan C.H., Wang X.Z., Zhao L.Y., and Li S.H. [Expression of cellular repressor of E1A-stimulated genes in vascular smooth muscle cells of different phenotypes]. Zhonghua Yi Xue Za Zhi 85 (2005) 49-53
12. Han Y.L., Guo P., Sun M.Y., Guo L., Luan B., Kang J., Yan C.H., Li S.H., and Secreted C. inhibits cell proliferation mediated by mannose 6-phosphate/insulin-like growth factor II receptor in NIH3T3 fibroblasts. Genes Cells 13 (2008) 977-986
13. Han Y., Guo L., Yan C., Guo P., Deng J., Mai X., Kang J., and Li S. Adenovirus-mediated intra-arterial delivery of cellular repressor of E1A-stimulated genes inhibits neointima formation in rabbits after balloon injury. J. Vasc. Surg. 48 (2008) 201-209
14. Veal E., Groisman R., Eisenstein M., and Gill G. The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cells. Oncogene 19 (2000) 2120-2128
15. De Souza A.T., Yamada T., Mills J.J., and Jirtle R.L. Imprinted genes in liver carcinogenesis. FASEB J. 11 (1997) 60-67
16. Kang J.X., Bell J., Leaf A., Beard R.L., and Chandraratna R.A. Retinoic acid alters the intracellular trafficking of the mannose-6-phosphate/insulin-like growth factor II receptor and lysosomal enzymes. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13687-13691
17. Oka Y., Rozek L.M., and Czech M.P. Direct demonstration of rapid insulin-like growth factor II Receptor internalization and recycling in rat adipocytes. Insulin stimulates 125I-insulin-like growth factor II degradation by modulating the IGF-II receptor recycling process. J. Biol. Chem. 260 (1985) 9435-9442
18. Maenaka S., Hikichi T., Imai M.A., Minamoto T., and Kawahara E. Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection. Oncol. Rep. 15 (2006) 791-795
19. Morali O.G., Jouneau A., McLaughlin K.J., Thiery J.P., and Larue L. IGF-II promotes mesoderm formation. Dev. Biol. 227 (2000) 133-145
20. Li S., Sims S., Jiao Y., Chow L.H., and Pickering J.G. Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes. Circ. Res. 85 (1999) 338-348
21. Zaina S., Pettersson L., Ahren B., Branen L., Hassan A.B., Lindholm M., Mattsson R., Thyberg J., and Nilsson J. Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. J. Biol. Chem. 277 (2002) 4505-4511
22. Codina M., Garcia de la serrana D., Sanchez-Gurmaches J., Montserrat N., Chistyakova O., Navarro I., and Gutierrez J. Metabolic and mitogenic effects of IGF-II in rainbow trout (Oncorhynchus mykiss) myocytes in culture and the role of IGF-II in the PI3K/Akt and MAPK signalling pathways. Gen. Comp. Endocrinol. 157 (2008) 116-124
23. Kim J., Song G., Gao H., Farmer J.L., Satterfield M.C., Burghardt R.C., Wu G., Johnson G.A., Spencer T.E., and Bazer F.W. Insulin-like growth factor II activates phosphatidylinositol 3-kinase-protooncogenic protein kinase 1 and mitogen-activated protein kinase cell Signaling pathways, and stimulates migration of ovine trophectoderm cells. Endocrinology 149 (2008) 3085-3094
24. Sacher M., Di Bacco A., Lunin V.V., Ye Z., Wagner J., Gill G., and Cygler M. The crystal structure of CREG, a secreted glycoprotein involved in cellular growth and differentiation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18326-18331
25. Blanchard F., Duplomb L., Raher S., Vusio P., Hoflack B., Jacques Y., and Godard A. Mannose 6-Phosphate/Insulin-like growth factor II receptor mediates internalization and degradation of leukemia inhibitory factor but not signal transduction. J. Biol. Chem. 274 (1999) 24685-24693
26. Kanaki T., Bujo H., Mori S., Yanjuan Z., Takahashi K., Yokote K., Morisaki N., and Saito Y. Functional analysis of aortic endothelial cells expressing mutant PDGF receptors with respect to expression of matrix metalloproteinase-3. Biochem. Biophys. Res. Commun. 294 (2002) 231-237
27. Kenagy R.D., Hart C.E., Stetler-Stevenson W.G., and Clowes A.W. Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation 96 (1997) 3555-3560
28. Duan C., Bauchat J.R., and Hsieh T. Phosphatidylinositol 3-kinase is required for insulin-like growth factor-I-induced vascular smooth muscle cell proliferation and migration. Circ. Res. 86 (2000) 15-23
29. Imai Y., and Clemmons D.R. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I. Endocrinology 140 (1999) 4228-4235
30. Small T.W., Bolender Z., Bueno C., O'Neil C., Nong Z., Rushlow W., Rajakumar N., Kandel C., Strong J., Madrenas J., and Pickering J.G. Wilms' tumor 1-associating protein regulates the proliferation of vascular smooth muscle cells. Circ. Res. 99 (2006) 1338-1346
31. Henney A.M., Wakeley P.R., Davies M.J., Foster K., Hembry R., Murphy G., and Humphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 8154-8158
32. Lendon C.L., Davies M.J., Born G.V., and Richardson P.D. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis 87 (1991) 87-90
33. Amour A., Slocombe P.M., Webster A., Butler M., Knight C.G., Smith B.J., Stephens P.E., Shelley C., Hutton M., Knauper V., Docherty A.J., and Murphy G. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435 (1998) 39-44
34. Ghosh P., Dahms N.M., and Kornfeld S. Mannose 6-phosphate receptors: new twists in the tale. Nat. Rev. Mol. Cell. Biol. 4 (2003) 202-212
35. Bayes-Genis A., Conover C.A., and Schwartz R.S. The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ. Res. 86 (2000) 125-130